Baylor Charles Sammons Cancer Center

Dallas, Texas 75246

0 studies enrolling now · 2 studies all time

What they study most

Castrate Resistent Prostate Cancer, Refractory Diffuse Large B-Cell Lymphoma, Relapsed Diffuse Large B-Cell Lymphoma

Studies at this site

• Ibrutinib in Combination With Lenalidomide and Rituximab in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma — Completed
• Safety Study of BPX-201 Dendritic Cell Vaccine Plus AP1903 in Metastatic Castrate Resistent Prostate Cancer — Completed